Genentech, Inc. Follow / Connect - Business Profile & Social Media Wall / Press Room - Pharma / BioTech / Nutrition

Genentech, Inc. Company Profile & Social Media Wall Press Room - Press Releases

Founded more than 30 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California.

	Company Name:	Genentech, Inc.
	Trading Symbol(s):	[SIX: RO, ROG; OTCQX: RHHB]
	Contact:	Press Office - Gene.com
	Address:	Confidential
	City:	San Francisco
	Zip code:	94080
	STATE / Prov.:	CA
	Country:	United States
	Primary Industry:	Pharma / BioTech / Nutrition
	PR Agency:	No

Your Company Advertising Here!
Showing along with this industry
- Learn more...

Latest Articles:
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization - [ Pharma / BioTech / Nutrition ]
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab) - [ Pharma / BioTech / Nutrition ]
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer - [ Pharma / BioTech / Nutrition ]
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting - [ Pharma / BioTech / Nutrition ]
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe - [ Pharma / BioTech / Nutrition ]
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application - [ Pharma / BioTech / Nutrition ]
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy - [ Pharma / BioTech / Nutrition ]
FDA Grants Breakthrough Therapy Designation for Genentech’s Actemra® (Tocilizumab) in Giant Cell Arteritis, a Form of Vasculitis - [ Pharma / BioTech / Nutrition ]
Genentech Provides Update on Phase III Study of Gazyva® in People with Previously Untreated Diffuse Large B-Cell Lymphoma - [ Pharma / BioTech / Nutrition ]
FDA Approves Genentech’s Xolair® (omalizumab) for Allergic Asthma in Children - [ Pharma / BioTech / Nutrition ]
FDA Grants Priority Review for Genentech’s OCREVUS™ (Ocrelizumab) Biologics License Application - [ Pharma / BioTech / Nutrition ]
Phase III Study Shows Genentech’s Actemra® (tocilizumab) Maintained Steroid-Free Remission in People with Giant Cell Arteritis (GCA) - [ Pharma / BioTech / Nutrition ]
FDA Grants Genentech’s Cancer Immunotherapy TECENTRIQ™ (atezolizumab) Accelerated Approval for People with a Specific Type of Advanced Bladder Cancer - [ Pharma / BioTech / Nutrition ]
Genentech Announces FDA Grants Venclexta™ (Venetoclax) Accelerated Approval for People with a Hard-To-Treat Type of Chronic Lymphocytic Leukemia - [ Pharma / BioTech / Nutrition ]
FDA Grants Priority Review for Genentech’s Cancer Immunotherapy Atezolizumab in Specific Type of Lung Cancer - [ Pharma / BioTech / Nutrition ]
FDA Grants Genentech’s Cancer Immunotherapy Atezolizumab Priority Review for Advanced Bladder Cancer - [ Pharma / BioTech / Nutrition ]
FDA Files Genentech’s Supplemental Biologics License Application of Xolair® (omalizumab) for Pediatric Allergic Asthma - [ Pharma / BioTech / Nutrition ]
Genentech Provides Update on Two Identical Phase III Studies of Lebrikizumab in People with Severe Asthma - [ Pharma / BioTech / Nutrition ]
FDA Grants Breakthrough Therapy Designation for Genentech’s Investigational Medicine Ocrelizumab in Primary Progressive Multiple Sclerosis - [ Pharma / BioTech / Nutrition ]
FDA Grants Genentech’s Alecensa® (Alectinib) Accelerated Approval for People with a Specific Type of Lung Cancer - [ Pharma / BioTech / Nutrition ]
Genentech’s Ocrelizumab First Investigational Medicine to Show Positive Pivotal Study Results - [ Pharma / BioTech / Nutrition ]
FDA Grants Breakthrough Therapy Designation for Actemra (tocilizumab) in Systemic Sclerosis - [ Pharma / BioTech / Nutrition ]
Pivotal Data for Genentech Medicines in Lung and Blood Cancers to be Presented at ASCO - [ Pharma / BioTech / Nutrition ]
Genentech Announces Plans to Expand Hillsboro Facility - [ Pharma / BioTech / Nutrition ]
FDA Grants Genentech's Cobimetinib Priority Review for Use in Combination with Zelboraf (Vemurafenib) in Advanced Melanoma - [ Pharma / BioTech / Nutrition ]

« Previous Page

Next Page »

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business

ó See your Ad Here! ó

PREMIUM Members

ó See your Logo Here! ó